{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:06:29Z","timestamp":1795147589279,"version":"4.10.3"},"reference-count":20,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.vaccine.2021.07.022","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T02:15:46Z","timestamp":1626747346000},"page":"4778-4783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant"],"prefix":"10.1016","volume":"39","author":[{"given":"Hayley","family":"Colton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3733-2717","authenticated-orcid":false,"given":"Diana M.","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6819-3476","authenticated-orcid":false,"given":"John A.","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4357-4392","authenticated-orcid":false,"given":"Paul D.E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Morley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2209-9956","authenticated-orcid":false,"given":"Thomas C.","family":"Darton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cariad M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thushan I.","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2021.07.022_b0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.022_b0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.vaccine.2021.07.022_b0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2021.07.022_b0020","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bmt.2016.362","article-title":"Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: A survey of UK NHS programmes","volume":"52","author":"Miller","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.022_b0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbmt.2006.12.207","article-title":"203: Vaccination against infection after haemopoietic stem cell transplant","volume":"13","author":"Gilleece","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.vaccine.2021.07.022_b0030","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2021.07.022_b0035","first-page":"417","article-title":"Weekly epidemiological record: Diptheria Position Paper","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"10","key":"10.1016\/j.vaccine.2021.07.022_b0040","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.bbmt.2017.06.006","article-title":"Measuring Immune Response to Commonly Used Vaccinations in Adult Recipients of Allogeneic Hematopoietic Cell Transplantation","volume":"23","author":"Kennedy","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.022_b0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/CVI.00735-14","article-title":"Use and Clinical Interpretation of Pneumococcal Antibody Measurements in the Evaluation of Humoral Immune Function","volume":"22","author":"Daly","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2021.07.022_b0050","unstructured":"Bailey H. Screening for varicella in pregnancy: External review against programme appraisal criteria for the UK National Screening Committee (UK NSC) 2015:1\u201327."},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.022_b0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcv.2008.08.012","article-title":"Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay","volume":"44","author":"Maple","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2021.07.022_b0060","unstructured":"Ramsay M. Pneumococcal: the green book, chapter 25. Public Heal Engl 2018:Last updated 18 Jan 2018."},{"issue":"49","key":"10.1016\/j.vaccine.2021.07.022_b0065","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1016\/j.vaccine.2012.09.029","article-title":"Immunity to tetanus and diphtheria in the UK in 2009","volume":"30","author":"Wagner","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2021.07.022_b0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bmt.1704634","article-title":"Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease","volume":"34","author":"Ljungman","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.vaccine.2021.07.022_b0075","unstructured":"Ramsay M. Chapter 34 Varicella. Green B 2015;3:421\u201342."},{"issue":"4","key":"10.1016\/j.vaccine.2021.07.022_b0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/376997","article-title":"Estimating Haemophilus influenzae Type b Vaccine Effectiveness in England and Wales by Use of the Screening Method","volume":"188","author":"Ramsay","year":"2003","journal-title":"J Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2021.07.022_b0085","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1017\/S0950268817001546","article-title":"A systematic review of varicella seroprevalence in European countries before universal childhood immunization: Deriving incidence from seroprevalence data","volume":"145","author":"Bollaerts","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.07.022_b0090","unstructured":"England PH. Guidelines on Post-Exposure Prophylaxis for measles 2019:1\u201324."},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.022_b0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.annonc.2019.11.005","article-title":"Reduced seroprevalence against vaccine preventable diseases (VPDs) in adult patients with cancer: necessity of routine vaccination as part of the therapeutic concept","volume":"31","author":"Guzek","year":"2020","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.vaccine.2021.07.022_b0100","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1586\/14760584.2014.944167","article-title":"Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: Recent epidemiology","volume":"13","author":"Sheridan","year":"2014","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:58:49Z","timestamp":1759402729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21008811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":20,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0264410X21008811"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}